Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Liver Malignancy 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Hepatocellular 1

Interventions

Yttrium-90 1Radiosurgery 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Liver Malignancy × Yttrium-90 × Clear all
NCT04518748 2025-08-05

Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.

University of Michigan Rogel Cancer Center

Phase 1 Recruiting
70 enrolled

Liver Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡